摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1-methyl-1H-benzimidazol-2-yl)-N-(4-methylphenyl)pyrimidin-2-amine | 1383074-00-7

中文名称
——
中文别名
——
英文名称
4-(1-methyl-1H-benzimidazol-2-yl)-N-(4-methylphenyl)pyrimidin-2-amine
英文别名
4-(1-methylbenzimidazol-2-yl)-N-(4-methylphenyl)pyrimidin-2-amine
4-(1-methyl-1H-benzimidazol-2-yl)-N-(4-methylphenyl)pyrimidin-2-amine化学式
CAS
1383074-00-7
化学式
C19H17N5
mdl
——
分子量
315.377
InChiKey
AYDBKOFFSNZNIW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    2-Anilino-4-(benzimidazol-2-yl)pyrimidines – A multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines
    摘要:
    2-Anilino-4-(benzimidazol-2-yl)-pyrimidines, synthesized by reaction of a readily available benzimidazole-substituted enaminone with suitable arylguanidines, were shown to inhibit four cancer-related protein kinases (Aurora B, PLK1, FAK, and VEGF-R2). The most potent derivative exhibited antiproliferative activity for several cancer cell lines of the NCI in vitro cell line panel in submicromolar concentrations. Both the anilinopyrimidine structure and the substitution pattern at the aniline ring appear to be important for the protein kinase inhibitory activity. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.04.007
点击查看最新优质反应信息

文献信息

  • 2-Anilino-4-(benzimidazol-2-yl)pyrimidines – A multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines
    作者:Renate Determann、Jan Dreher、Knut Baumann、Lutz Preu、Peter G. Jones、Frank Totzke、Christoph Schächtele、Michael H.G. Kubbutat、Conrad Kunick
    DOI:10.1016/j.ejmech.2012.04.007
    日期:2012.7
    2-Anilino-4-(benzimidazol-2-yl)-pyrimidines, synthesized by reaction of a readily available benzimidazole-substituted enaminone with suitable arylguanidines, were shown to inhibit four cancer-related protein kinases (Aurora B, PLK1, FAK, and VEGF-R2). The most potent derivative exhibited antiproliferative activity for several cancer cell lines of the NCI in vitro cell line panel in submicromolar concentrations. Both the anilinopyrimidine structure and the substitution pattern at the aniline ring appear to be important for the protein kinase inhibitory activity. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多